Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF (NYSEMKT: PBE)
$64.06
(0.8%)
$0.49
Price as of May 3, 2024, 3:27 p.m. ET
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF Company Info
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index.
News & Analysis
Featured Article
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
Keith Speights | Nov 9, 2023
Featured Article
3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett
Warren Buffett is a phenomenal investor -- but if you do these three things you could become a more successful health care investor than Buffett will ever be!
Sean Williams | Mar 9, 2014
A Simple Path to Biotechnology Winners
Selena Maranjian | Nov 1, 2012
One of these even sports a dividend yield above 7%.
Don't Miss These Health-Care ETFs
Dave Williamson | Feb 28, 2011
Two ways ETFs can help your portfolio
Diversifying in the ETF Universe
Zoe Van Schyndel, CFA | Aug 17, 2006
You don't need to worry about diworsification. Add a smart balance to your portfolio with the right mix of ETFs.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.